Pembro Plus CAR T-cell Therapy in R/R in PMBCL

Clinical trial NCT05934448 · RECRUITING

Trial details

NCT number: NCT05934448
Sponsor: Jennifer Crombie, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Mediastinal Large B-cell Lymphoma (PMBCL)Primary Mediastinal Large B Cell Lymphoma Primary Mediastinal Large B-Cell Lymphoma Refractory Primary Mediastinal Large B-Cell Lymphoma Recurrent Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma T-Cell/Histiocyte-Rich Large B-Cell Lymphoma

Start date: 2023-11-15
Primary completion: 2027-06-06
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.